|
시장보고서
상품코드
1907998
오피오이드계 의약품 시장 : 약제 클래스별, 용도별, 투여 경로별, 유통 채널별, 지역별Opioid Drugs Market, By Drug Class, By Application, By Route of Administration, By Distribution Channel, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 오피오이드계 의약품 시장은 2025년 480억 2,000만 달러 규모로 추정되었으며, 2032년까지 602억 7,000만 달러에 이를 것으로 예측됩니다. 2025년부터 2032년까지는 연평균 복합 성장률(CAGR) 3.3%로 성장할 것으로 전망됩니다.
| 보고서 커버 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준 연도: | 2024년 | 2025년 시장 규모: | 480억 2,000만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2025-2032년 |
| 예측 기간(2025-2032년) CAGR: | 3.30% | 2032년 예측: | 602억 7,000만 달러 |
오피오이드는 주로 통증 완화에 사용되는 약물의 일종입니다. 최초의 오피오이드계 의약품의 하나인 모르핀은 1803년에 개발되었습니다. 오피오이드계 의약품은 중추신경계 및 말초신경계에 존재하는 오피오이드 수용체에 작용하여 통증을 완화시킵니다. 오피오이드는 경구 정제, 비경구 투여, 용액, 패치 또는 로젠지 형태로 투여됩니다. 처방전이 필요한 오피오이드에는 펜타닐, 옥시코돈, 모르핀, 코데인, 옥시몰폰, 하이드로코돈 등 다양한 유형이 있으며 의사가 통증 치료를 위해 처방합니다.
시장 역학
오피오이드 수용체와 뉴로키닌 수용체를 표적으로 하는 하이브리드 화합물의 합성에 대한 연구개발 증가는 시장 관계자들에게 수익성 높은 성장 기회를 가져올 것으로 예측됩니다. 예를 들어, 2019년 12월에는 루지 의과대학의 연구자들이 오피오이드 약물 분자구조와 서브스탠스 P(SP) 단편 또는 뉴로키닌 수용체(NK1) 길항제 단편을 조합해 합쳐진 일련의 하이브리드 화합물의 합성, 구조활성 상관, 약리학적 특성 평가에 대해 보고하고, 오피오이드 유발성 항 통각작용에서 뉴로키닌계의 역할의 해명에 임하고 있습니다.
시장의 주요 기업은 제품 포트폴리오를 확대하기 위해 제품 승인 및 출시에 주력하고 있습니다. 예를 들어, 2018년 6월에는 전문 의약품 기업인 AcelRx Pharmaceuticals, Inc.가 의료 감시하에서 성인의 급성 중등도에서 중증 통증 관리를 목적으로 한 DZUVEO에 대해 유럽 위원회(EC)의 승인을 취득했습니다. 시장에서는 M&A 활동이 증가하는 경향이 있습니다. 예를 들어, Grunenthal은 미국에서 사업을 확장하기 위해 미국에 본사를 둔 제약 회사 "Averitas Pharma"를 인수했습니다.
본 조사의 주요 특징
- 본 보고서는 2024년을 기준으로 하여 예측 기간 중(2025-2032년) 세계의 오피오이드계 의약품 시장 규모를 제시하고 상세한 분석을 제공합니다.
- 각 부문에서 잠재적인 수익 기회를 밝히는 동시에 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
- 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품의 발매 또는 승인, 지역별 전망, 주요 기업이 채용하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 이 보고서는 다음 매개 변수를 기반으로 세계의 오피오이드계 의약품 시장에서 주요 기업을 프로파일링합니다 - 기업 개요, 재무 실적, 제품 포트폴리오, 지리적 존재, 유통 전략, 주요 발전 및 전략, 미래 계획
- 이 보고서의 인사이트는 각 회사의 마케팅 담당자와 경영진이 향후 제품 투입, 기술 업그레이드, 시장 확대, 마케팅 전략에 관한 정보를 바탕으로 의사 결정을 내리는 데 도움이 될 것입니다.
- 세계의 오피오이드계 의약품 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진출기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해 관계자는 세계의 오피오이드계 의약품 시장 분석에 이용되는 다양한 전략 매트릭스를 통해 의사 결정을 쉽게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 범위
- 보고서 개요
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 시장 기회
- 영향 분석
- 최근 제품 출시
- 역학
- 합병, 인수 및 제휴
- 규제 환경
- 주요 발전
- 상환 상황
- PEST 분석
- Porter's Five Forces 분석
제4장 세계의 오피오이드계 의약품 시장 : 약제 클래스별, 2020-2032년
- 알칼로이드
- 반합성 오피오이드
- 합성 오피오이드
제5장 세계의 오피오이드계 의약품 시장 : 용도별, 2020-2032년
- 진통
- 기침 억제
- 설사 억제
제6장 세계의 오피오이드계 의약품 시장 : 투여 경로별, 2020-2032년
- 경구
- 국소
- 비경구
- 기타(근육내 주사 등)
제7장 세계의 오피오이드계 의약품 시장 : 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제8장 세계의 오피오이드계 의약품 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카 국가
- 유럽
- 영국
- 독일
- 이탈리아
- 프랑스
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- ASEAN
- 호주
- 한국
- 기타 아시아태평양
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 북아프리카
- 중앙 아프리카
- 남아프리카
제9장 경쟁 구도
- 기업 프로파일
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma LP
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals LP
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals(USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited
제10장 섹션
- 참고문헌
- 조사 방법
Opioid Drugs Market is estimated to be valued at USD 48.02 Bn in 2025 and is expected to reach USD 60.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 48.02 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 3.30% | 2032 Value Projection: | USD 60.27 Bn |
Opioids are a class of drugs which are largely used for relieving pain. One of the first opioid drugs 'morphine' was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous system thus providing relief from pain. Opioid are administered in the form of as oral pills, parenteral, liquids, patches or lozenges. There are different types of prescription opioids available such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone which are prescribed by physicians for treating pain.
Market Dynamics
Increasing R&D in synthesis of hybrids targeting opioid and neurokinin receptors is expected to offer lucrative growth opportunities for market players. For instance, in December 2019, researchers from Medical University of Lodz reported the synthesis, structure-activity relationship, and pharmacological characterization of a series of hybrids combining opioid pharmacophores with either substance P (SP) fragments or neurokinin receptor (NK1) antagonist fragments in order to comprehend the role of the neurokinin system in opioid-induced antinociception.
Key players in the market are focused on product approvals and launches to expand their product portfolio. For instance, in June 2018, AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company received the European Commission (EC) approval for DZUVEO for the management of acute moderate to severe pain in adults in medically monitored settings. The market is witnessing increasing merger and acquisition activities. For instance, Grunenthal acquired the U.S.-based pharmaceutical company 'Averitas Pharma' in order to expand its presence in the U.S.
Key features of the study
- This report provides an in-depth analysis of global opioids market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global opioids market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global opioids market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global opioids market
Market Segmentation
- Drug Class Insights (Revenue, USD Bn, 2025 - 2032)
- Alkaloids
- Semisynthetic Opioids
- Synthetic Opioids
- Application Insights (Revenue, USD Bn, 2025 - 2032)
- Analgesia
- Cough Suppression
- Diarrhea Suppression
- Route of Administration Insights (Revenue, USD Bn, 2025 - 2032)
- Oral
- Topical
- Parenteral
- Others
- Distribution Channel Insights (Revenue, USD Bn, 2025 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2025 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- Key Players Insights
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Endo International plc
- Lupin Limited
- Cadila Healthcare Limited
- Purdue Pharma L.P.
- AbbVie Inc.
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Rhodes Pharmaceuticals L.P.
- Sun Pharmaceutical Industries Limited
- Nesher Pharmaceuticals (USA) LLC
- Amneal Pharmaceuticals LLC
- Trevena Inc.
- Aurobindo Pharma Limited
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- Reimbursement Scenario
- PEST Analysis
- PORTER'S Analysis
4. Global Opioid Drugs Market, By Drug Class, 2020- 2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Alkaloids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Morphine
- codeine
- Semisynthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Oxycodone
- Hydrocodone
- Hydromorphone
- Synthetic Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Fentanyl
- Alfentanil
5. Global Opioid Drugs Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
6. Global Opioid Drugs Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
- Others (Intramuscular, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Segment Trends
7. Global Opioid Drugs Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Opioid Drugs Market, By Region, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020-2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (USD Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2020-2032, (USD Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 -2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Endo International plc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Cadila Healthcare Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Purdue Pharma L.P.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Fresenius Kabi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Mallinckrodt Pharmaceuticals
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Rhodes Pharmaceuticals L.P.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sun Pharmaceutical Industries Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Nesher Pharmaceuticals (USA) LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Amneal Pharmaceuticals LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Trevena Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Aurobindo Pharma Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Teva Pharmaceutical Industries Ltd.
10. Section
- References
- Research Methodology
- About us and Sales Contact
샘플 요청 목록